BioCentury | Jul 22, 2020
Emerging Company Profile

Deep Longevity: Insilico spinout clocks biological age

...Deep Longevity’s launch follows the emergence of several companies developing anti-aging therapeutics, including AI company Fountain Therapeutics Inc....
...Los Angeles Insilico Medicine Inc. Human Longevity Inc. ETP Ventures Bold Capital Partners Longevity Vision Fund Juvenescence Ltd. Life Biosciences LLC Unity Biotechnology Inc. Fountain Therapeutics Inc....
BioCentury | Jul 16, 2020
Emerging Company Profile

Fountain Therapeutics: an AI-based platform to reverse cellular aging

...we start focusing more on aging as the root cause of many of these diseases.” Fountain Therapeutics Inc....
...the formation of Juvenomics Ltd. (see “Rejuvenating Aging” ; “Juvenescence’s Market Watch” ). COMPANY PROFILE Fountain Therapeutics Inc....
Items per page:
1 - 2 of 2
BioCentury | Jul 22, 2020
Emerging Company Profile

Deep Longevity: Insilico spinout clocks biological age

...Deep Longevity’s launch follows the emergence of several companies developing anti-aging therapeutics, including AI company Fountain Therapeutics Inc....
...Los Angeles Insilico Medicine Inc. Human Longevity Inc. ETP Ventures Bold Capital Partners Longevity Vision Fund Juvenescence Ltd. Life Biosciences LLC Unity Biotechnology Inc. Fountain Therapeutics Inc....
BioCentury | Jul 16, 2020
Emerging Company Profile

Fountain Therapeutics: an AI-based platform to reverse cellular aging

...we start focusing more on aging as the root cause of many of these diseases.” Fountain Therapeutics Inc....
...the formation of Juvenomics Ltd. (see “Rejuvenating Aging” ; “Juvenescence’s Market Watch” ). COMPANY PROFILE Fountain Therapeutics Inc....
Items per page:
1 - 2 of 2